Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Sleep ...
PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images ...
A task force of experts commissioned by the American Academy of Sleep Medicine (AASM) have released updated recommendations for the treatment of central sleep apnea, published in the Journal of ...
Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more ...
Sleep apnea is widely underappreciated as a cardiovascular risk factor, a treatable one that primary-care physicians should consider on par with dyslipidemia and hypertension, according to Dr Barbara ...
The FDA clearance follows the presentation of SANSA clinical performance data earlier this year at the SLEEP meeting. The study, drawing on data collected from 325 patients across 7 clinical sites, ...
Green Matters on MSN
Sleep apnea sufferers may soon be able to reach for a pill to deal with their condition
Researchers believe that a drug used to treat childhood epilepsy may also be good for assisting with sleep apnea-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results